The Drugs Controller General of India has given restricted emergency use authorization to BharatBiotech’s Covaxin for children between the age of 6-12 years.
,
The Drugs Controller General of India has given restricted emergency use authorization to BharatBiotech’s Covaxin for children between the age of 6-12 years.
,